SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 419.49 |
Enterprise Value ($M) | 395.94 |
Book Value ($M) | 30.26 |
Book Value / Share | 0.12 |
Price / Book | 13.86 |
NCAV ($M) | 8.46 |
NCAV / Share | 0.03 |
Price / NCAV | 49.56 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.55 |
Return on Assets (ROA) | -0.65 |
Return on Equity (ROE) | -0.82 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.87 |
Current Ratio | 1.87 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 30.00 |
Assets | 51.79 |
Liabilities | 21.53 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6.04 |
Operating Income | -65.53 |
Net Income | -63.08 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -62.05 |
Cash from Investing | 3.08 |
Cash from Financing | 20.88 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 4.69 | 1.52 | |
13G/A | State Street Corp | 0.33 | -86.23 | |
13G/A | BlackRock Inc. | 1.50 | -74.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
517,921 | 2,062,601 | 25.11 | |
482,992 | 1,896,454 | 25.47 | |
648,393 | 2,233,422 | 29.03 | |
655,034 | 2,878,217 | 22.76 | |
708,782 | 2,418,583 | 29.31 | |
(click for more detail) |
Similar Companies | |
---|---|
NTBL – Notable Labs, Ltd. | NVCT – Nuvectis Pharma, Inc. |
OCEA – Ocean Biomedical, Inc. | OCUP – Ocuphire Pharma, Inc. |
OCX – OncoCyte Corporation |
Financial data and stock pages provided by
Fintel.io